Barrier Medical, a prominent player in medical device innovation, has received a significant nod from the Medicines and Healthcare products Regulatory Agency (MHRA) with the approval of their new Class 1 device – a patient arm support designed to reduce radiation scatter in catheterization theatres.
This cutting-edge device marks a notable advancement in patient care and safety within interventional cardiology and radiology settings. The arm support’s primary function is to enhance the positioning of a patient’s arm during procedures, thereby significantly minimizing the amount of scattered radiation that medical staff are exposed to.
Radiation safety in catheterization labs is a growing concern, with healthcare professionals often subjected to prolonged and repeated exposure. Barrier Medical’s device addresses this critical issue, aligning with the increasing emphasis on improving occupational safety standards in medical environments.
With MHRA’s approval, Barrier Medical sets a benchmark for innovative solutions aimed at safeguarding healthcare workers’ health while ensuring optimal patient care. The company is poised to begin distribution within the UK shortly, and there are plans to expand to international markets. The approval reinforces Barrier Medical’s commitment to advancing medical safety and improving the operational environment for healthcare professionals.